Mexico - Delayed Quote • MXN Novartis AG (NVSN.MX) Follow Add holdings 2,092.19 0.00 (0.00%) At close: May 12 at 7:32:02 AM CST Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for NVSN.MX 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: NVSN.MX View More All News Press Releases SEC Filings RHHBY to Invest $1.25B to Boost Manufacturing Footprint in US Drugmakers Avoid Worst-Case Pricing Scenario for Now European Equities Close Higher in Monday Trading as US, China Truce Relieves Investors Market Chatter: Novartis to Continue Malaria Drug Production Despite Uncertain Demand Trump’s Plan to Cut Drug Prices Hits Pfizer, Other Pharma Stocks Novartis to keep making malaria drugs if orders dry up amid aid cuts Biotech Alert: Searches spiking for these stocks today Novartis to Acquire Regulus in $1.7 Billion Deal Novartis to acquire Regulus Therapeutics and farabursen, an investigational microRNA inhibitor to treat ADPKD, the most common genetic cause of renal failure Novartis Scores A Beat-And-Raise Quarter — And Shares Make A Break For A Buy Point Novartis Lifts Guidance After Profit, Sales Top Views